• reduce regulatory burdens such as prior authorization; ensure telehealth flexibilities; improve healthcare outcomes for all urologic disease states; ensure access to prostate cancer screenings; address urologic workforce shortages; promote urologic research funding; preserve in-office exceptions to the Stark Law; support policies to protect physician interests in the utilization of electronic health records systems; encourage drug pricing implementation and negotiations that do not hinder urologists ability to provide patient access to all pharmaceuticals or therapies.
• promote permanent reforms for Medicare physician payment and reimbursement that provide stability for all practice models

Duration: January 1, 2008 to present

General Issues: Health Issues, Medicare/Medicaid

Spending: about $5,423,885 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Veterans Affairs - Dept of (VA), Food & Drug Administration (FDA), U.S. Senate,, Natl Institutes of Health (NIH), Agency for Health Care Policy & Research